Short answer
Solid Biosciences Inc. (SLDB) filed an 8-K current report with the SEC on April 10, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers). Ilan Ganot shifted from Class III to Class I effective April 10, 2026, preserving equal Board-class membership.
Solid Biosciences Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Ilan Ganot shifted from Class III to Class I effective April 10, 2026, preserving equal Board-class membership
- Class III director count decreased to three; Class I increased to three
- Ganot’s new Class I term runs through the 2028 Annual Meeting, avoiding re-election at the 2027 meeting
- Stockholders will advisory-ratify Ganot’s appointment at the 2026 Annual Meeting
- No compensation changes or payments resulting from the move, limiting financial impact
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Solid Biosciences Inc. 8-K filings
Get the next SLDB 8-K as it lands
Follow SLDB for push alerts, or ask the research agent what this filing means.